Sign in

Research summary ·

Efficacy and Safety of Plasma Exchange and Immunoadsorption for Acute Optic Neuritis in Patients with Demyelinating Diseases: A Systematic Review and Meta-Analysis.

Written based on 1 research study on PubMed, searched on 15 Nov 2026.

What was studied

This review looked at optic neuritis, which can harm sight. It can occur with diseases such as MS, NMOSD and MOGAD. Steroids are often given first, but many people do not fully recover. The team pooled data from past studies of plasma exchange and immunoadsorption. They searched for studies up to January 2025. Both were used as rescue care when steroids were not enough.

What they found

The review took in studies with more than 800 attacks. Both treatments were linked to a clear gain in sight. Starting early went with better results. People with MOGAD had the highest rate of response. In NMOSD, late treatment was linked to worse sight. Side effects were rare and mild.

What it means for patients

The authors say both treatments work and are safe after steroids fail. They say this is true above all when care starts early. In their view, the results back quick use of these treatments. The aim would be to help people get their sight back.

Why it is not certain yet

The studies had different designs. Their quality was judged with different tools. The abstract does not give the results of those quality checks. It also does not say how many studies had a comparison group. The abstract gives few details on each treatment alone. A review can only be as good as the studies in it.

Source

Efficacy and Safety of Plasma Exchange and Immunoadsorption for Acute Optic Neuritis in Patients with Demyelinating Diseases: A Systematic Review and Meta-Analysis.

PubMed · PMID 42415978

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Optic neuritis publications